Pages that link to "Q28578563"
Jump to navigation
Jump to search
The following pages link to MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression (Q28578563):
Displaying 50 items.
- Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells (Q24601584) (← links)
- Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury (Q24629732) (← links)
- The impact of hypoxia on intestinal epithelial cell functions: consequences for invasion by bacterial pathogens (Q26752794) (← links)
- Targeting hypoxic response for cancer therapy (Q26767351) (← links)
- Personalized characterization of diseases using sample-specific networks (Q28586781) (← links)
- Mucin 1, cell surface associated (Q29517126) (← links)
- Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth (Q33572229) (← links)
- YC-1 induces G0/G1 phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells (Q33821469) (← links)
- MUC1: a multifaceted oncoprotein with a key role in cancer progression (Q33880143) (← links)
- Impact of MUC1 mucin downregulation in the phenotypic characteristics of MKN45 gastric carcinoma cell line (Q34071695) (← links)
- Expression of MUC17 is regulated by HIF1α-mediated hypoxic responses and requires a methylation-free hypoxia responsible element in pancreatic cancer (Q34412211) (← links)
- Reduced mRNA expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer (Q34680677) (← links)
- O-glycan profiling of serum glycan for potential renal cancer biomarkers (Q34777759) (← links)
- Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis (Q35723085) (← links)
- Muc1 is protective during kidney ischemia-reperfusion injury (Q35749664) (← links)
- Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma (Q35799377) (← links)
- MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer (Q36187161) (← links)
- Adrenomedullin 2 (ADM2) Regulates Mucin 1 at the Maternal-Fetal Interface in Human Pregnancy (Q36461998) (← links)
- Hypoxia-regulated target genes implicated in tumor metastasis (Q36521763) (← links)
- Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist (Q36777133) (← links)
- Update on vaccine development for renal cell cancer (Q36989720) (← links)
- Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas. (Q37040588) (← links)
- N-acetylgalactosaminyltransferases in cancer (Q37619873) (← links)
- Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. (Q37627345) (← links)
- MUC1 and metastatic cancer: expression, function and therapeutic targeting (Q37636939) (← links)
- Eukaryotic protein glycosylation: a primer for histochemists and cell biologists (Q37639440) (← links)
- High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma (Q37702565) (← links)
- MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathway. (Q37718458) (← links)
- The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma (Q37964960) (← links)
- A novel personalized vaccine approach in combination with targeted therapy in advanced renal cell carcinoma (Q38172644) (← links)
- MUC1: a novel metabolic master regulator (Q38177983) (← links)
- Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma. (Q38697133) (← links)
- Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy (Q38759490) (← links)
- Establishment of a human 3D lung cancer model based on a biological tissue matrix combined with a Boolean in silico model (Q39037578) (← links)
- Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease (Q39080461) (← links)
- MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors (Q39251872) (← links)
- Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia (Q39387590) (← links)
- Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways (Q39465548) (← links)
- Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells (Q40413253) (← links)
- Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival (Q41576862) (← links)
- Mitochondrial deficiency impairs hypoxic induction of HIF-1 transcriptional activity and retards tumor growth (Q42244179) (← links)
- A new age for vaccine therapy in renal cell carcinoma (Q42857032) (← links)
- Changes in pulmonary tissue structure and KL-6/MUC1 expression in a newborn rat model of hyperoxia-induced bronchopulmonary dysplasia (Q44740176) (← links)
- Analysis of an ADTKD family with a novel frameshift mutation in MUC1 reveals characteristic features of mutant MUC1 protein (Q47331609) (← links)
- Differential expression and clinical relevance of MUC1 in renal cell carcinoma metastasis. (Q53142704) (← links)
- MUC1 expression in pulmonary metastatic tumors: a comparison of primary lung cancer. (Q53199232) (← links)
- Metastasis in renal cell carcinoma: Biology and implications for therapy. (Q54936635) (← links)
- Increased expression of MUC1 and sialyl Lewis antigens in different areas of clear renal cell carcinoma (Q87500480) (← links)
- Cancer-associated fibroblasts-stimulated interleukin-11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1 (Q88514840) (← links)
- Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus (Q92668499) (← links)